Rigel Pharmaceuticals (RIGL) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -53.62% |
| Jun 30, 2025 | -52.60% |
| Mar 31, 2025 | -50.64% |
| Dec 31, 2024 | -46.80% |
| Sep 30, 2024 | -43.49% |
| Jun 30, 2024 | -40.42% |
| Mar 31, 2024 | -38.57% |
| Dec 31, 2023 | -34.67% |
| Sep 30, 2023 | -33.68% |
| Jun 30, 2023 | -32.05% |
| Mar 31, 2023 | -27.21% |
| Dec 31, 2022 | -0.41% |
| Sep 30, 2022 | 13.01% |
| Jun 30, 2022 | 13.28% |
| Mar 31, 2022 | 14.83% |
| Dec 31, 2021 | 13.57% |
| Sep 30, 2021 | 15.46% |
| Jun 30, 2021 | 11.01% |
| Mar 31, 2021 | 9.18% |
| Dec 31, 2020 | 10.65% |
| Sep 30, 2020 | 6.73% |
| Jun 30, 2020 | 5.64% |
| Mar 31, 2020 | 4.26% |
| Dec 31, 2019 | -2.96% |
| Sep 30, 2019 | -9.70% |
| Jun 30, 2019 | -14.89% |
| Mar 31, 2019 | -16.65% |
| Dec 31, 2018 | -20.81% |
| Sep 30, 2018 | -21.40% |
| Jun 30, 2018 | -22.92% |
| Mar 31, 2018 | -24.42% |
| Dec 31, 2017 | -31.56% |
| Sep 30, 2017 | -30.97% |
| Jun 30, 2017 | -30.63% |
| Mar 31, 2017 | -28.91% |
| Dec 31, 2016 | -25.03% |
| Sep 30, 2016 | -24.35% |
| Jun 30, 2016 | -21.09% |
| Dec 31, 2015 | -18.67% |